Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | MDM4 | O15151 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | LCK | P06239 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19299630 | 0.84 | MAOB (0.42) | MAOBNPSR1KMT2AALDH1A1KDM4E | |
| SCHEMBL1445721 | 0.80 | ALDH1A1 (0.47) | MAOBALDH1A1KDM4ELCKLMNA | |
| SCHEMBL16086041 | 0.77 | NPSR1 (0.38) | MAOBNPSR1KMT2AALDH1A1KDM4E | |
| SCHEMBL14667355 | 0.76 | HTT (0.53) | NPSR1ALDH1A1KDM4ECA12CA1 | |
| SCHEMBL14671037 | 0.76 | TSHR (0.53) | MAOBALDH1A1KDM4ELMNAMAPT | |
| SCHEMBL14519900 | 0.76 | ALDH1A1 (0.57) | MAOBNPSR1KMT2AALDH1A1LCK | |
| SCHEMBL12489653 | 0.75 | LMNA (0.41) | KMT2AALDH1A1CA1CA2LMNA | |
| SCHEMBL15401983 | 0.73 | CYP2C19 (0.46) | ALDH1A1KDM4ETP53LMNAMAPT | |
| SCHEMBL19283203 | 0.73 | ALDH1A1 (0.58) | MAOBNPSR1KMT2AALDH1A1KDM4E | |
| SCHEMBL22430504 | 0.73 | KMT2A (0.44) | MAOBNPSR1KMT2AALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9670364-B2 | Compound having xanthene skeleton, colorant composition, ink for inkjet recording, inkjet recording method, inkjet printer cartridge, and inkjet recording material | FUJIFILM CORPORATION (JP) | 2017-06-06 | — | — | US | disclosed |
| US-20160208102-A1 | COMPOUND HAVING XANTHENE SKELETON, COLORANT COMPOSITION, INK FOR INKJET RECORDING, INKJET RECORDING METHOD, INKJET PRINTER CARTRIDGE, AND INKJET RECORDING MATERIAL | FUJIFILM CORPORATION (JP) | 2016-07-21 | — | — | US | disclosed |
| US-20140004458-A1 | MAGENTA TONER | CANON KABUSHIKI KAISHA (JP) | 2014-01-02 | — | — | US | disclosed |
| US-8343269-B2 | Colorant compound | CANON KABUSHIKI KAISHA (JP) | 2013-01-01 | — | — | US | disclosed |
| EP-2302001-B1 | Xanthene-based colorant compound | CANON KK (JP) | 2012-12-05 | — | — | EP | disclosed |
| EP-2302001-A1 | Xanthene-based colorant compound | Canon Kabushiki Kaisha (JP) | 2011-03-30 | — | — | EP | disclosed |
| US-20110067598-A1 | COLORANT COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110067598-A1 | COLORANT COMPOUND | CNOT9, RB1, PRMT9 | MAOB 173/4885NPSR1 3044/4885KMT2A 1113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.